Back

Effect of hospital Intensive lipid-lowering protocol on low density lipoprotein cholesterol control and clinical outcomes in patients with acute myocardial infarction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (2) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shimpei Fujioka

Osaka Medical and Pharmaceutical University hospital, Osaka (Japan)

3 More presentations in this session

Presentation thumbnail
Design and initial results of the Canadian lipoprotein(a) registry
Associate Professor L. Brunham (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Elevated Lp(a) in primary and secondary prevention in Greece: prevalence and clinical relevance
Doctor G. Zervas (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Marked variability in reporting of low-density lipoprotein cholesterol values: a national review of pathology providers in Australia
Doctor R. Ma (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Efficacy of combination lipid lowering therapy in achieving low density lipoprotein cholesterol targets after one month of event in patients with acute coronary syndrome
thumbnail
Congress Presentation
Optimizing lipid control after acute coronary syndrome: can we strike early and strong in real-world practice?
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources